Why We Dilate Your Eyes
Patients often ask why we must dilate their eyes. A dilated retina exam is essential to properly diagnosing and monitoring a number of retina conditions, including diabetic retinopathy, macular degeneration and retinal tears or detachment. Your
read more
September is Sports Eye Safety Month
According to Prevent Blindness, there were 43,379 sports-related eye injuries treated in the United States in 2024, an increase of 33 percent from the previous year. Basketball had the highest rate of
read more
Offices Closed for Labor Day on 9/1/25
All Texas Retina offices will be closed on Monday, September 1, 2025, in observance of Labor Day. We wish everyone a safe and happy holiday weekend!
read more
Why Your Appointment May Take Longer Than Anticipated
We often have patients and family members ask why they have to wait or why their appointment is taking so long, especially if they see other patients called back before them. We
read more
Texas Retina Research Team Members Attended Ollin Study Meeting in Maui
This past weekend, seven members of Texas Retina’s research team were invited to attend the Ollin Study Coordinators meeting in Maui, Hawaii. Ollin is a Phase Ib study of two different formulations
read more
July is UV Safety Month — Debunking Seven Common Myths About Sunglasses
When most people think of UV protection, they think of their skin and sunscreen. Did you know that long-term exposure to bright sunlight may also increase your risk of eye disease? July
read more
Offices Closed on Friday, July 4, 2025
All Texas Retina offices will be closed on Friday, July 4, 2025, in recognition of the Independence Day holiday and will reopen on Monday, July 7. We wish everyone a safe and
read more
June is Fireworks Eye Safety Awareness Month
Summer is here, and for many that means outdoor celebrations that include fireworks, especially around the 4th of July. Unfortunately, this also means an increase in eye injuries. Here are a few
read more
Dr. Abbey Presented Study Results of Two Investigational Wet AMD Treatments at Clinical Trials Summit
This past weekend, Texas Retina’s Director of Clinical Research for Dallas Ashkan M. Abbey, MD, led two presentations at the annual Clinical Trials at the Summit (CTS) meeting in Las Vegas, which
read more
Initial Results of Phase Ib LOTUS Clinical Trial on Potential New Diabetic Macular Edema Treatment Released
On June 9, 2025, Eluminex Biosciences Limited, a clinical-stage protein therapeutics company, announced positive topline safety, tolerability, and pharmacodynamic data from the multicenter LOTUS Part 1 clinical trial of EB-105 in patients
read more